Skip to content

What is the intrinsic test for B12? A guide to intrinsic factor antibody testing

4 min read

According to the NIH, an Intrinsic Factor Antibody (IFAB) test is used to detect antibodies that block vitamin B12 absorption, and it is a key diagnostic tool for pernicious anemia. This article explains what is the intrinsic test for B12, its purpose, procedure, and how it is used today compared to the now-obsolete Schilling test.

Quick Summary

The intrinsic test for B12 is the intrinsic factor antibody test, a modern blood test used to diagnose pernicious anemia by detecting autoantibodies that interfere with vitamin B12 absorption. It has largely replaced the older, more complex Schilling test.

Key Points

  • Intrinsic Factor Antibody Test: The modern 'intrinsic test for B12' is a blood test detecting antibodies that block the absorption of vitamin B12, primarily used to diagnose pernicious anemia.

  • Obsolete Schilling Test: This older, multi-stage procedure involving radioactive B12 and urine collection is no longer used due to its complexity and the availability of newer, simpler tests.

  • Pernicious Anemia Diagnosis: A positive intrinsic factor antibody test provides strong evidence for pernicious anemia, an autoimmune disorder causing B12 deficiency.

  • Negative Results are Not Conclusive: Up to 50% of patients with pernicious anemia may have negative intrinsic factor antibody results, so a negative test does not rule out the condition.

  • Comprehensive Testing: To get a full picture of B12 status, clinicians often use a combination of tests, including serum B12, methylmalonic acid (MMA), and parietal cell antibodies.

  • Intrinsic Factor's Role: Intrinsic factor is a stomach protein that binds to vitamin B12, enabling its absorption in the small intestine. Without it, B12 deficiency occurs.

  • Purpose of Testing: The intrinsic test helps determine the specific cause of a B12 deficiency, guiding the most appropriate treatment, which can range from dietary changes to B12 injections.

In This Article

Understanding the role of intrinsic factor

Intrinsic factor (IF) is a glycoprotein produced by the parietal cells of the stomach lining. Its critical function is to bind with vitamin B12 (cobalamin), which is released from food by stomach acid. This binding creates a complex that allows the vitamin to be absorbed in the final part of the small intestine, called the ileum. Without intrinsic factor, vitamin B12 cannot be absorbed, leading to a deficiency regardless of dietary intake. This deficiency can result in a type of anemia called pernicious anemia, along with neurological and other systemic issues.

The modern intrinsic factor antibody test

Unlike the older Schilling test, the intrinsic factor antibody (IFAB) test is a simple blood test. It is used to help diagnose the cause of vitamin B12 deficiency, specifically by confirming or ruling out pernicious anemia, an autoimmune condition.

How the IFAB test works

The test detects two types of autoantibodies that the immune system might produce against intrinsic factor.

  • Type 1 (blocking antibodies): These antibodies block the binding site on the intrinsic factor molecule, preventing it from attaching to vitamin B12. They are more specific to pernicious anemia and are the type most commonly tested.
  • Type 2 (binding or precipitating antibodies): These antibodies interfere with the uptake of the B12-IF complex in the small intestine.

Interpreting the results

  • A positive result for intrinsic factor antibodies strongly suggests pernicious anemia. It indicates that the body's immune system is attacking its own intrinsic factor, disrupting B12 absorption.
  • A negative result does not completely rule out pernicious anemia, as a significant portion of affected patients do not test positive for these antibodies. In such cases, other tests may be used to confirm the diagnosis.

The obsolete Schilling test

For many years, the Schilling test was the standard for investigating vitamin B12 absorption. This multi-stage procedure involved using radioactive vitamin B12 and collecting urine over a 24-hour period. The test is now considered obsolete due to its complexity, the use of radioactive materials, and the development of more accurate and convenient blood tests.

The Schilling test stages explained

  1. Stage 1: Oral B12 with a flushing injection. The patient ingested radioactive vitamin B12 followed by a large, non-radioactive B12 injection. The injection saturates the body's B12 stores so any absorbed radioactive B12 is excreted in the urine. Low excretion indicated a malabsorption issue.
  2. Stage 2: Oral B12 with intrinsic factor. If Stage 1 showed low excretion, the test was repeated with additional oral intrinsic factor. If this corrected the absorption, it indicated that the issue was a lack of intrinsic factor, diagnosing pernicious anemia.
  3. Stages 3 and 4 (if needed): These later stages involved antibiotics or pancreatic enzymes to test for other potential causes of malabsorption, like bacterial overgrowth or pancreatic insufficiency.

Comparison of B12 intrinsic factor tests

Feature Intrinsic Factor Antibody (IFAB) Test Schilling Test (Obsolete)
Procedure Simple blood draw. Multi-stage test involving oral doses, injections, and 24-hour urine collections.
Use of Radioactivity None. Uses radiolabeled vitamin B12.
Convenience Highly convenient, requires minimal patient preparation. Inconvenient, requiring timed urine collections and multiple appointments.
Underlying Principle Detects autoimmune antibodies targeting intrinsic factor. Measures the body's actual absorption of vitamin B12.
Specificity High specificity for pernicious anemia when positive. Can differentiate between several causes of malabsorption.
Sensitivity Poor sensitivity; a negative result doesn't rule out pernicious anemia. High diagnostic value when performed correctly.
Status Current standard diagnostic method for pernicious anemia. Obsolete due to modern advances and inconvenience.

Additional tests for B12 deficiency

The intrinsic factor antibody test is just one piece of the diagnostic puzzle. A comprehensive evaluation for vitamin B12 deficiency often includes other tests, especially when the IFAB result is negative or symptoms persist.

Common supplementary tests

  • Serum B12 level: A basic blood test to measure total vitamin B12 concentration. It's not a definitive indicator of deficiency, as it can be falsely low or high.
  • Methylmalonic acid (MMA): A blood or urine test that measures MMA levels, which become elevated when B12 is deficient. It is considered a more sensitive and reliable indicator of true deficiency than a serum B12 level alone.
  • Homocysteine: Elevated homocysteine levels can also signal a B12 deficiency, but they can be influenced by other factors, including folate status.
  • Parietal cell antibody test: Detects antibodies targeting the stomach's parietal cells, which produce intrinsic factor. These antibodies are present in about 90% of pernicious anemia cases but are less specific than IFAB.
  • Holotranscobalamin (Active B12): Measures the amount of vitamin B12 that is actually available for cells to use, offering a more accurate assessment than total serum B12.

Conclusion

The question, "what is the intrinsic test for B12?", refers to the modern intrinsic factor antibody (IFAB) test, which is a blood test used to diagnose pernicious anemia by detecting autoantibodies. It has replaced the complex and now-obsolete Schilling test. While a positive IFAB test is a strong indicator of pernicious anemia, a negative result is not conclusive, and a comprehensive diagnosis typically involves additional tests like MMA, homocysteine, and parietal cell antibody checks. A thorough diagnostic process is essential for identifying the root cause of B12 deficiency and determining the most effective treatment plan.

Note: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment of any health condition. Source: Testing.com: Intrinsic Factor Antibody Test

Frequently Asked Questions

The primary purpose of the intrinsic factor antibody (IFAB) test is to help diagnose pernicious anemia, an autoimmune condition where the body's immune system attacks intrinsic factor or the cells that produce it, leading to vitamin B12 malabsorption.

No, a negative IFAB test does not entirely rule out pernicious anemia. Only about half of people with the condition will test positive for the antibodies. Other tests, such as parietal cell antibody or methylmalonic acid (MMA), may be needed for a conclusive diagnosis.

The intrinsic factor antibody test is a simple blood test that has replaced the Schilling test. The Schilling test was a multi-stage procedure that used radioactive B12 and was less convenient and more complex. The IFAB test is now the standard method for determining intrinsic factor issues.

There are two types: Type 1 (blocking antibodies), which prevent intrinsic factor from binding to vitamin B12, and Type 2 (binding antibodies), which hinder the absorption of the B12-IF complex. Type 1 is more specific for pernicious anemia and is the most common one tested.

If intrinsic factor is not functioning properly, the body cannot absorb vitamin B12 effectively from food. This leads to a B12 deficiency, which can cause megaloblastic anemia, neurological symptoms, and other health issues associated with pernicious anemia.

Besides pernicious anemia, a B12 deficiency can arise from other conditions that affect intrinsic factor production or function. These include atrophic gastritis, gastric bypass surgery, and inherited disorders like Imerslund-Gräsbeck syndrome.

Your doctor would typically order an IFAB test if you have a confirmed vitamin B12 deficiency to investigate whether the underlying cause is pernicious anemia. It helps distinguish between malabsorption due to autoimmune factors versus other causes like diet or medication.

References

  1. 1
  2. 2
  3. 3
  4. 4

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.